Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1985 | 12-1984 | 12-1983 | 12-1982 | 12-1981 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 17,389 | 13,258 | 16,409 | 12,320 | 11,732 |
| TOTAL | $17,389 | $13,258 | $16,409 | $12,320 | $11,732 |
| Non-Current Assets | |||||
| PPE Net | 266,519 | 254,676 | 245,250 | 240,210 | 231,230 |
| Investments And Advances | 2,983 | 2,694 | 3,108 | 4,089 | 4,575 |
| Other Non-Current Assets | 5,332 | 6,465 | 6,384 | 6,380 | 5,005 |
| TOTAL | $274,834 | $263,835 | $254,742 | $250,679 | $240,810 |
| Total Assets | $292,223 | $277,093 | $271,151 | $262,999 | $252,542 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,242 | 10,638 | 15,543 | 13,848 | 10,156 |
| Accounts payable and accrued liabilities | 29,221 | 26,201 | 28,703 | 26,470 | 24,294 |
| Accrued Expenses | 3,352 | 4,849 | 4,695 | 5,122 | 6,074 |
| TOTAL | $86,080 | $74,459 | $74,429 | $74,238 | $67,397 |
| Non-Current Liabilities | |||||
| TOTAL | $43,496 | $41,612 | $40,473 | $33,882 | $25,885 |
| Total Liabilities | $129,576 | $116,071 | $114,902 | $108,120 | $93,282 |
| Shareholders' Equity | |||||
| Common Shares | 102,143 | 26,486 | 26,105 | 25,720 | 25,420 |
| TOTAL | $102,143 | $33,381 | $32,506 | $31,734 | $31,213 |
| Total Liabilities And Equity | $231,719 | $149,452 | $147,408 | $139,854 | $124,495 |